Walgreens Boots Alliance, Inc. (WBA)

NASDAQ:
WBA
| Latest update: Oct 15, 2025, 6:55 PM

Stock events for Walgreens Boots Alliance, Inc. (WBA)

The past six months have been transformative for Walgreens Boots Alliance's stock. In March 2025, the company announced an agreement to be taken private by Sycamore Partners in a deal valued at $10 billion. On June 26, 2025, WBA released its Q3 FY25 earnings, with analysts projecting a significant 48.29% decline in earnings per share (EPS) to 32 cents, and subdued revenue expectations of $35.8 billion. On August 25, 2025, Deutsche Bank downgraded WBA to a "sell" rating. On August 28, 2025, Sycamore Partners completed the acquisition of Walgreens Boots Alliance, leading to the company's delisting from Nasdaq and its division into five separate entities. On October 6, 2025, the merger was completed, and shareholders received 1 CVR (Contingent Value Right) plus $11.45 USD for each share previously held.

Demand Seasonality affecting Walgreens Boots Alliance, Inc.’s stock price

Walgreens Boots Alliance's products and services have exhibited demand seasonality. While the company experienced an uptrend in quarterly revenue since 2022, this growth tended to slow down, particularly in the second half of each year. The third quarter typically showed the least performing change in revenue.

Overview of Walgreens Boots Alliance, Inc.’s business

Walgreens Boots Alliance, Inc. (WBA) operated as a pharmacy-led health and beauty retail company, providing prescription and non-prescription drugs, health and wellness products, beauty and personal care items, household goods, convenience foods, and photofinishing services. Its major brands included Walgreens and Duane Reade in the U.S., Boots in the UK, and global health and beauty brands such as No7, Soltan, Botanics, NICE!, Finest Nutrition, YourGoodSkin, Soap & Glory, Liz Earle, and Sleek MakeUP.

WBA’s Geographic footprint

Before becoming private, Walgreens Boots Alliance had a significant international presence, operating in more than 9 countries and having operations in approximately 25 countries. Its pharmacy-led retail businesses were present in 11 countries, while its pharmaceutical wholesale and distribution network extended to 19 countries. The majority of the company's revenue was generated from the U.S. market, where it operated Walgreens and Duane Reade stores. Internationally, its retail pharmacy businesses included Boots in the United Kingdom, Ireland, Norway, Netherlands, and Thailand, as well as Benavides in Mexico and Ahumada in Chile. The company also had pharmaceutical wholesale operations in Germany.

WBA Corporate Image Assessment

In the past year, Walgreens Boots Alliance's reputation has been impacted by several challenges, including a class action lawsuit alleging false statements regarding revenue outlook and risks, leading to a stock price decline. The company has also faced severe structural issues, including margin compression, falling earnings, and a weak balance sheet. Furthermore, uncertainties surrounding pending litigation and regulatory actions, including potential financial risks from opioid-related lawsuits and Pharmacy Benefit Manager (PBM) practices, have also affected its standing.

Ownership

Prior to its privatization, Walgreens Boots Alliance had a substantial institutional ownership, with approximately 61.65% of the company's shares held by institutional investors as of March 2025. Major institutional owners included Vanguard Group Inc, BlackRock, Inc., State Street Corp, Invesco Ltd., Fmr Llc, FIL Ltd, Geode Capital Management, Llc, Norges Bank, and Capital Research and Management Company. Insiders held a smaller percentage, approximately 0.74% as of March 2025. With the completion of the acquisition by Sycamore Partners, the company is now privately owned.

Price Chart

$0.00

0.00%
(1 month)

No data available

There is no data available for the selected date range.

Top Shareholders

The Vanguard Group, Inc.
9.64%
BlackRock, Inc.
5.94%
State Street Corp.
3.73%
Invesco Ltd.
2.68%
FMR LLC
2.57%
483A Bay Street Holdings LP
2.38%
Geode Holdings Trust
2.22%
Government of Norway
2.02%
The Charles Schwab Corp.
1.77%
Morgan Stanley
1.41%
UBS Group AG
1.41%
Candlestick Capital Management LP
0.97%
Northern Trust Corp.
0.90%
Silver Point Capital LP
0.81%
Allianz SE
0.65%
GFH CSEVA LLC
0.64%
The Bank of New York Mellon Corp.
0.59%
Balyasny Asset Management Holdings LP
0.57%
James David Dondero
0.51%
Deutsche Bank AG
0.47%

Trade Ideas for WBA

Today

Sentiment for WBA

News
Social

Buzz Talk for WBA

Today

Social Media

FAQ

What is the current stock price of Walgreens Boots Alliance, Inc.?

As of the latest update, Walgreens Boots Alliance, Inc.'s stock is trading at $0.00 per share.

What’s happening with Walgreens Boots Alliance, Inc. stock today?

Today, Walgreens Boots Alliance, Inc. stock is stable by 0.00%, possibly due to news.

What is the market sentiment around Walgreens Boots Alliance, Inc. stock?

Current sentiment around Walgreens Boots Alliance, Inc. stock is negative, based on recent news, trading volume, and analyst opinions.

Is Walgreens Boots Alliance, Inc.'s stock price growing?

Over the past month, Walgreens Boots Alliance, Inc.'s stock price has unknown by 0.00%.

How can I buy Walgreens Boots Alliance, Inc. stock?

You can buy Walgreens Boots Alliance, Inc. stock through any brokerage platform, such as e.g., Robinhood, Fidelity, E*TRADE, by searching for the ticker symbol WBA

Who are the major shareholders of Walgreens Boots Alliance, Inc. stock?

Major shareholders of Walgreens Boots Alliance, Inc. include institutions such as The Vanguard Group, Inc. (9.64%), BlackRock, Inc. (5.94%), State Street Corp. (3.73%) ... , according to the latest filings.